"RSV Prevention and Immunization" - Amanda Novack, MD

In 2023 multiple RSV vaccinations were approved. This talk details prevention strategies for at-risk populations, as well as guides you to help your patients who need immunization gain access to vaccines. 

Speaker bio: Dr. Amanda Novack is an Arkansas native who graduated from Hendrix College and earned her medical degree from UAMS. She completed a residency in Internal Medicine and a fellowship in Infectious Diseases at UAMS as well. She served as faculty there for two years, with an emphasis on expediting discharges and optimizing home IV antibiotics. She worked with the Arkansas Department of Health providing statewide education about antimicrobial stewardship and infection prevention, and eventually served on the medical staff of 15 hospitals, providing consultation for hospital policy, as well as individual patients through telemedicine and in-person visits. In November 2019, she was named Medical Director of Infection Prevention for Baptist Health, and led much of the system’s response to the COVID-19 pandemic. Since 2022 she has been the Vice President of Quality and Safety for the Baptist Health system, and she continues to live in Little Rock with her family and too many dogs. 

At the completion of the presentation, attendees should be able to: 

1. Compare the preventative options for RSV infection
2. Describe the populations who should receive RSV vaccination
3. Discuss the utility of Beyfortus for RSV prevention in neonates
4. Identify resources to help fund RSV immunizations for your patients

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 19 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Approval is valid from 3/8/2024 to 3/8/2025. AAPA reference number: CME-2010808.

None.